// App-Quantinova.ai

403 : Single-specificity Anti-SMN Autoantibodies Are Associated with a Novel Scleromyositis Overlap Syndrome

Researchers

Presenter

  • Alexandra Baril-Dionne

Principal Investigators

  • Alain Meyer

  • Josiane Bourre-Tessier

  • Yves Troyanov

  • Anne-Marie Mansour

  • Farah Zarka

  • Jean-Paul Makhzoum

  • Jessica Nehme

  • Eric Rich

  • Jean-Richard Goulet

  • Tamara Grodzicky

  • Isabelle Richard

  • Marie Hudson

  • Valerie Leclair

  • Ira Targoff

  • Minoru Satoh

  • Marvin Fritzler

  • Jean-Luc Senecal

Medical Centers

  • Centre Hospitalier de LUniversite de Montreal (CHUM), Montreal, QC, Canada

  • Division of Rheumatology, Centre hospitalier de l'Université de Montréal; Department of Medicine, Université de Montréal, Montreal, QC, Canada

  • Centre de Reference des Maladies Autoimmunes Rares, Hôpitaux Universitaires de Strasbourg, Strasbourg, France

  • Division of Rheumatology, Department of Medicine, Hôpital du Sacre-Coeur de Montreal, Montreal, QC, Canada

  • Hopital du Sacre-Coeur de Montreal, Montreal, QC, Canada

  • Vasculitis Clinic, Hopital du Sacre-Coeur de Montreal, Montreal, QC, Canada

  • CISSS AT Rouyn-Noranda, Rouyn-Noranda, QC, Canada

  • Jewish General Hospital, Lady Davis Institute for Medical Research, McGill University, Montreal, QC, Canada

  • Division of Rheumatology, Department of Medicine, Jewish General Hospital; Clinical Epidemiology Unit, Department of Medicine, Karolinska Institutet, Montreal, QC, Canada

  • University of Oklahoma Health Sciences Center, Oklahoma City, OK

  • Department of Clinical Nursing, School of Health Sciences, University of Occupational and Environmental Health, Kitakyushu, Japan

  • Cumming School of Medicine, University of Calgary, Calgary, AB, Canada

Locations

  • Canada

  • France

  • United States

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

  • Autoimmune (AI)

Disease

  • Autoimmune sclerosing cholangitis

  • Myositis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A